BiBBInstruments EndoDrill GI

The solution in TO1 will accelerate the launch of EndoDrill GI

A letter of intent has been signed and commercialization of EndoDrill GI is now underway. The focus is initially on the USA, where BiBBInstruments...

Medicinteknik
26th of May 2025
Fredrik Lindblad, CEO, BiBBInstruments

BiBBInstruments about LOI: "It's a very good match"

BiBBInstruments recently signed a letter of intent with TaeWoong – an important step towards a final partnership agreement. CEO Fredrik Lindblad explains...

8th of May 2025
BiBBInstruments signs letter of intent

BiBB writes LOI for launch in the USA

BiBBInstruments has signed a letter of intent (LOI) with TaeWoong Medical USA to launch the EndoDrill GI biopsy instrument on the American market...

6th of May 2025
Fredrik Lindblad, CEO, BiBBInstruments

BiBBInstruments: “The goal is to have an agreement before the summer holidays”

The reporting season is in full swing and BiBBInstruments has now reported its first quarter for 2025. BioStock met with CEO Fredrik...

30th April 2025

BibbInstruments founder on clinical evaluations of EndoDrill GI

BiBBInstruments founder Charles Walther has recently traveled to clinics in different parts of the world where EndoDrill...

March 26, 2025
BiBB on the key to commercial success

BiBBInstruments CEO: "Agreements with distribution partners will be the key to commercial success"

BiBB begins 2025 with a commercial breakthrough, with EndoDrill GI now in use by the first paying customer. With more...

March 5, 2025
BiBB_Firstorder

BiBBInstruments CEO: "First order sends positive signals"

January 28
BibbInstruments conducts sampling

Issue kicks off BiBBInstruments' market launch

Clinical evaluation of BiBBInstruments' endoscopic sampling instrument has yielded very promising results. Good usability combined with high quality of the samples...

January 13
BiBBInstruments presents in BioStock Investor Pitch

BioStock Investor Pitch: BiBBInstruments

BiBBInstruments, which is currently issuing shares, is preparing for the launch of the endoscopic sampling instrument EndoDrill GI. Usability combined with high-quality samples means that interest...

January 9
BiBBInstruments CEO Fredrik Lindblad

BiBBInstruments prepares for market launch – BioStock takes the pulse of the CEO

EndoDrill GI is being evaluated at several clinics around Europe and the USA. The company behind the new sampling instrument, BiBBInstruments, is conducting...

January 7
BiBBInstruments CEO Fredrik Lindblad

BiBBInstruments CEO: "The issue will finance our entry into the commercial phase"

Launch is just around the corner for BiBBInstruments, which spent a lot of effort and energy last year on clinical evaluation of EndoDrill...

January 3
BiBBInstruments enters Sahlgrenska

BiBBInstruments founder about the evaluation at Sahlgrenska

BiBBInstruments takes another step in the clinical evaluation of EndoDrill GI. Recently, Sahlgrenska University Hospital in Gothenburg joined...

November 19